RNA logo

Avidity Biosciences, Inc. (RNA) Long Term Liabilities

Annual Long Term Liabilities:

$40.92M-$6.19M(-13.15%)
December 31, 2024

Summary

  • As of today, RNA annual total long term liabilities is $40.92 million, with the most recent change of -$6.19 million (-13.15%) on December 31, 2024.
  • During the last 3 years, RNA annual long term liabilities has risen by +$24.43 million (+148.11%).
  • RNA annual long term liabilities is now -73.09% below its all-time high of $152.03 million, reached on December 31, 2019.

Performance

RNA Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRNAbalance sheet metrics

Quarterly Long Term Liabilities:

$78.06M+$36.86M(+89.47%)
September 30, 2025

Summary

  • As of today, RNA quarterly total long term liabilities is $78.06 million, with the most recent change of +$36.86 million (+89.47%) on September 30, 2025.
  • Over the past year, RNA quarterly long term liabilities has increased by +$32.01 million (+69.49%).
  • RNA quarterly long term liabilities is now -48.65% below its all-time high of $152.03 million, reached on December 31, 2019.

Performance

RNA Quarterly Long Term Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRNAbalance sheet metrics

Long Term Liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

RNA Long Term Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-13.2%+69.5%
3Y3 Years+148.1%+616.8%
5Y5 Years-73.1%+535.2%

RNA Long Term Liabilities Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-13.2%+364.1%at high+1127.0%
5Y5-Year-73.1%+364.1%at high+1127.0%
All-TimeAll-Time-73.1%+364.1%-48.6%+1127.0%

RNA Long Term Liabilities History

DateAnnualQuarterly
Sep 2025
-
$78.06M(+89.5%)
Jun 2025
-
$41.20M(-9.4%)
Mar 2025
-
$45.49M(+11.2%)
Dec 2024
$40.92M(-13.1%)
$40.92M(-11.2%)
Sep 2024
-
$46.06M(+9.2%)
Jun 2024
-
$42.18M(-7.5%)
Mar 2024
-
$45.62M(-3.2%)
Dec 2023
$47.11M(+434.3%)
$47.11M(+575.0%)
Sep 2023
-
$6.98M(+9.7%)
Jun 2023
-
$6.36M(-8.8%)
Mar 2023
-
$6.98M(-20.9%)
Dec 2022
$8.82M
$8.82M(-19.0%)
DateAnnualQuarterly
Sep 2022
-
$10.89M(-14.7%)
Jun 2022
-
$12.76M(-12.0%)
Mar 2022
-
$14.51M(-12.0%)
Dec 2021
$16.49M(+26.0%)
$16.49M(+91.3%)
Sep 2021
-
$8.62M(-11.2%)
Jun 2021
-
$9.71M(-12.7%)
Mar 2021
-
$11.12M(-15.0%)
Dec 2020
$13.09M(-91.4%)
$13.09M(+6.5%)
Sep 2020
-
$12.29M(-8.6%)
Jun 2020
-
$13.44M(-12.4%)
Mar 2020
-
$15.34M(-89.9%)
Dec 2019
$152.03M(+275.4%)
$152.03M
Dec 2018
$40.49M
-

FAQ

  • What is Avidity Biosciences, Inc. annual total long term liabilities?
  • What is the all-time high annual long term liabilities for Avidity Biosciences, Inc.?
  • What is Avidity Biosciences, Inc. annual long term liabilities year-on-year change?
  • What is Avidity Biosciences, Inc. quarterly total long term liabilities?
  • What is the all-time high quarterly long term liabilities for Avidity Biosciences, Inc.?
  • What is Avidity Biosciences, Inc. quarterly long term liabilities year-on-year change?

What is Avidity Biosciences, Inc. annual total long term liabilities?

The current annual long term liabilities of RNA is $40.92M

What is the all-time high annual long term liabilities for Avidity Biosciences, Inc.?

Avidity Biosciences, Inc. all-time high annual total long term liabilities is $152.03M

What is Avidity Biosciences, Inc. annual long term liabilities year-on-year change?

Over the past year, RNA annual total long term liabilities has changed by -$6.19M (-13.15%)

What is Avidity Biosciences, Inc. quarterly total long term liabilities?

The current quarterly long term liabilities of RNA is $78.06M

What is the all-time high quarterly long term liabilities for Avidity Biosciences, Inc.?

Avidity Biosciences, Inc. all-time high quarterly total long term liabilities is $152.03M

What is Avidity Biosciences, Inc. quarterly long term liabilities year-on-year change?

Over the past year, RNA quarterly total long term liabilities has changed by +$32.01M (+69.49%)
On this page